Denny Lanfear
Chief Executive Officer bij COHERUS BIOSCIENCES, INC.
Vermogen: 3 M $ op 31-03-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Mark Stolper | M | 52 | 3 jaar | |
| Lee Newcomer | M | 71 | 2 jaar | |
| Bryan Mcmichael | M | 46 | 3 jaar | |
| Todd Binder | M | - |
Neuvogen, Inc.
| - |
| Charles Newton | M | 53 | 2 jaar | |
| Kimberly Commins-Tzoumakas | F | 56 | 4 jaar | |
| Jill O'Donnell-Tormey | M | 68 | 2 jaar | |
| Michael A. Fleming | M | - | 10 jaar | |
| Mats Wahlström | M | 70 | 12 jaar | |
| Michael Brown | M | 82 | 33 jaar | |
| Joseph Goldstein | M | 83 | 33 jaar | |
| Neil Stahl | M | 67 | 33 jaar | |
| Ali Satvat | M | 46 | 10 jaar | |
| Rosh Dias | M | - | 2 jaar | |
| Richard L. Hameister | M | - | 3 jaar | |
| Paul Reider | M | 55 | 3 jaar | |
| Gerald Underwood | M | - | 29 jaar | |
| Patrice Gilooly | F | - | 26 jaar | |
| Kendall Mohler | M | 68 |
Neuvogen, Inc.
| - |
| Rebecca Sunshine | F | 61 | 10 jaar | |
| Michael Ryan | M | - | 1 jaar | |
| Andrew Murphy | M | 66 | 25 jaar | |
| Gordon Binder | M | 88 |
Neuvogen, Inc.
| - |
| Theresa M. LaVallee | M | 57 | 3 jaar | |
| Georgia Erbez | F | 57 | - | |
| Walter R. Perkins | M | - | 14 jaar | |
| Mark W. Frohlich | M | 62 |
Neuvogen, Inc.
| 3 jaar |
| Karen Kotz | F | - | 2 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Linda Higgins | M | 62 |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | - |
| Alan C. Mendelson | M | 76 | 1 jaar | |
| Michael Nazak | M | 66 |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | 6 jaar |
| Marc M. P. de Garidel | M | 66 | 15 jaar | |
| Kathryn Falberg | F | 63 | 6 jaar | |
| Madhavan Balachandran | M | 73 | 20 jaar | |
| Donald Hayden | M | 68 | 9 jaar | |
| Murray Goldberg | M | 79 | 20 jaar | |
| Kevin Sharer | M | 76 | 20 jaar | |
| Stephen Glover | M | 60 | 7 jaar | |
| McDavid Stilwell | M | 53 | 3 jaar | |
| Alan C. Herman | M | 76 | - | |
| Peter K. Watler | M | 62 | 12 jaar | |
| Stuart E. Builder | M | - | - | |
| V. Lawlis | M | 72 | 7 jaar | |
| John Smither | M | 71 | 6 jaar | |
| Frans Gustaf Wuite | M | 64 | - | |
| Nicholas Lee Gurreri | M | - | - | |
| Vincent R. Anicetti | M | 69 | 7 jaar | |
| William Ashton | M | 73 | 16 jaar | |
| Dee Grosso | F | - | - | |
| Martin Simonetti | M | 66 | 7 jaar | |
| Alex M. DePaoli | M | - |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | - |
| Mary Szela | F | 61 | 7 jaar | |
| Jerry D. Choate | M | 86 | - | |
| Timothy G. Whitten | M | 67 | 2 jaar | |
| Harry F. Hixson | M | 84 | 6 jaar | |
| Patricia A. Turney | F | 57 | 23 jaar | |
| Vladimir Vexler | M | 66 | 10 jaar | |
| David S. Arrington | M | - | - | |
| Frederick Gluck | M | 88 | 13 jaar | |
| David Baltimore | M | 86 | 21 jaar | |
| Gil Omenn | M | 83 | 27 jaar | |
| Judith C. Pelham | F | 78 | 22 jaar | |
| Susan Lundeen Smuck | F | 57 | 12 jaar | |
| James Healy | M | 58 | 8 jaar | |
| Geoffrey Allan | M | 70 | 10 jaar | |
| Graham K. Crooke | M | 65 | 11 jaar | |
| Samuel R. Nussbaum | M | 75 | 3 jaar | |
| Darlene P. Horton | M | 62 | - | |
| Andrew Knudten | M | - | 13 jaar | |
| Aron M. Knickerbocker | M | 54 | 4 jaar | |
| Urte Gayko | M | 53 | 9 jaar | |
| Joseph Hagan | M | 55 | 10 jaar | |
| David Lacey | M | 71 | 17 jaar | |
| Douglas Love | M | 56 | 2 jaar | |
| Mark Daniels | M | 61 | 21 jaar | |
| Eric Easom | M | 56 |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | 2 jaar |
| Yi Ning Zhao | M | 53 | 5 jaar | |
| Hui Tian | M | - | 9 jaar | |
| Alan B. Forsythe | M | - | - | |
| Kurt Gustafson | M | 56 | 18 jaar | |
| Brian Lian | M | - | 3 jaar | |
| David Alan Goodkin | M | - | 10 jaar | |
| Diane M. Palumbo | F | 70 | 12 jaar | |
| Alan Colowick | M | 61 | 6 jaar | |
| John F. Weidenbruch | M | 63 | 10 jaar | |
| Doug Farrar | M | 59 | 7 jaar | |
| George Morstyn | M | 73 | 11 jaar | |
| Matthew Moyle | M | 63 | 6 jaar | |
| David Hallal | M | 57 | 10 jaar | |
| Daniel Flynn | M | 70 | - | |
| Nick Abbott | M | - | 10 jaar | |
| Robin D. Campbell | M | 69 | 13 jaar | |
| John G. Adair | M | - | 6 jaar | |
| Bradley J. Maroni | M | 71 | 6 jaar | |
| Keith L. Klein | M | 60 | 15 jaar | |
| Carl LeBel | M | 65 | 10 jaar | |
| William Marshall | M | 60 | 10 jaar | |
| Frederick A. Fletcher | M | - | 10 jaar | |
| Donna French | M | 59 | 15 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 99 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Denny Lanfear
- Persoonlijk netwerk
